prikaz prve stranice dokumenta Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Izvorni znanstveni rad
Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
European Journal of Cancer Care, 26 (2017), 4; 12514-12520. https://doi.org/10.1111/ecc.12514
Bošković, Lidija; Gašparić, Maja; Petrić Miše, Branka; Petković, Marija; Gugić, Damir; Ban, Marija; Jazvić, Marijana; Dabelić, Nina; Belac-Lovasić, Ingrid; Vrdoljak, Eduard

Citirajte ovaj rad

Bošković, L., Gašparić, M., Petrić Miše, B., Petković, M., Gugić, D., Ban, M. ... Vrdoljak, E. (2017). Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.. European Journal of Cancer Care, 26. (4), 12514-12520. doi: 10.1111/ecc.12514

Bošković, Lidija, et al. "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.." European Journal of Cancer Care, vol. 26, br. 4, 2017, str. 12514-12520. https://doi.org/10.1111/ecc.12514

Bošković, Lidija, Maja Gašparić, Branka Petrić Miše, Marija Petković, Damir Gugić, Marija Ban, Marijana Jazvić, Nina Dabelić, Ingrid Belac Lovasić i Eduard Vrdoljak. "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.." European Journal of Cancer Care 26, br. 4 (2017): 12514-12520. https://doi.org/10.1111/ecc.12514

Bošković, L., et al. (2017) 'Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.', European Journal of Cancer Care, 26(4), str. 12514-12520. doi: 10.1111/ecc.12514

Bošković L, Gašparić M, Petrić Miše B, Petković M, Gugić D, Ban M, i sur.. Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.. European Journal of Cancer Care [Internet]. 2017. [pristupljeno 19.11.2024.];26(4):12514-12520. doi: 10.1111/ecc.12514

L. Bošković, et al., "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.", European Journal of Cancer Care, vol. 26, br. 4, str. 12514-12520, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:950893. [Citirano: 19.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:950893
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
AutorLidija Bošković
AutorMaja Gašparić
AutorBranka Petrić Miše
AutorMarija Petković
AutorDamir Gugić
AutorMarija Ban
AutorMarijana Jazvić
AutorNina Dabelić
AutorIngrid Belac-Lovasić
AutorEduard Vrdoljak
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za onkologiju i radioterapiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Onkologija
Sažetak (engleski)
The aim of this analysis was to evaluate adherence of Croatian oncologists to follow‐up criteria as suggested by the current national and international guidelines for women with breast cancer receiving adjuvant endocrine therapy. The use of clinical and diagnostic methods was documented in this prospective, non‐interventional, multicenter study. A total of 438 post‐menopausal patients receiving adjuvant endocrine treatment with non‐steroidal aromatase inhibitors were included. Average annual frequency for each clinical and diagnostic method was calculated. Median adjuvant endocrine treatment duration before study recruitment was 10.5 months (interquartile 4.7–26.6). Patients were followed up for an average 23.5 ± 4.9 months. Average number of oncological visits was 5.3. Mammograms were performed at mean annual frequency of 0.7, chest radiographs at 0.5, abdominal ultrasounds at 0.9, breast ultrasounds at 1.2, complete blood counts and chemistry panels at 1.7, carcinoembryonic antigen at 0.8, cancer antigen 15‐3 at 1.6, gynaecological examination at 0.3, and densitometry at mean annual frequency of 0.3. In conclusion, among post‐menopausal women with breast cancer receiving adjuvant endocrine therapy in this study, more unnecessary and unproven follow‐up procedures were done compared to the guidelines' recommendations.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaEuropean Journal of Cancer Care
Brojčani podacivol. 26, br. 4, str. 12514-12520
p-ISSN0961-5423
e-ISSN1365-2354
DOIhttps://doi.org/10.1111/ecc.12514
URN:NBNurn:nbn:hr:184:950893
Datum objave publikacije2017
URL dokumentahttp://bib.irb.hr/999241
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-03-01 13:29:43